Post-contrast enhancement as a clinical indicator of prognosis in patients with anaplastic astrocytoma

[1]  B. Scheithauer,et al.  The 2007 WHO Classification of Tumours of the Central Nervous System , 2007, Acta Neuropathologica.

[2]  A. Brandes,et al.  Prognostic factors for anaplastic astrocytomas , 2007, Journal of Neuro-Oncology.

[3]  Paul S Mischel,et al.  MR imaging correlates of survival in patients with high-grade gliomas. , 2005, AJNR. American journal of neuroradiology.

[4]  I. Ferrer,et al.  Prognostic Significance of O6-Methylguanine-DNA Methyltransferase Determined by Promoter Hypermethylation and Immunohistochemical Expression in Anaplastic Gliomas , 2005, Clinical Cancer Research.

[5]  K. Ichimura,et al.  Mutations in Rb1 pathway-related genes are associated with poor prognosis in Anaplastic Astrocytomas , 2005, British Journal of Cancer.

[6]  Alona Muzikansky,et al.  The prognostic significance of phosphatidylinositol 3-kinase pathway activation in human gliomas. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  T-Y Lee,et al.  CT imaging of angiogenesis. , 2003, The quarterly journal of nuclear medicine : official publication of the Italian Association of Nuclear Medicine (AIMN) [and] the International Association of Radiopharmacology.

[8]  Anthony Asher,et al.  Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project. , 2003, Journal of neurosurgery.

[9]  J. Acebes,et al.  Prognostic implication of clinical, radiologic, and pathologic features in patients with anaplastic gliomas , 2003, Cancer.

[10]  G. Reifenberger,et al.  The WHO Classification of Tumors of the Nervous System , 2002, Journal of neuropathology and experimental neurology.

[11]  M. Prados,et al.  Genetic subgroups of anaplastic astrocytomas correlate with patient age and survival. , 2001, Cancer research.

[12]  D. Louis,et al.  Glioma classification: a molecular reappraisal. , 2001, The American journal of pathology.

[13]  Z L Gokaslan,et al.  A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. , 2001, Journal of neurosurgery.

[14]  K. Skullerud,et al.  Prognostic significance of CT contrast enhancement within histological subgroups of intracranial glioma , 1998, Journal of Neuro-Oncology.

[15]  T. Byrne,et al.  Imaging of gliomas. , 1994, Seminars in oncology.

[16]  B. Scheithauer,et al.  The New WHO Classification of Brain Tumours , 1993, Brain pathology.

[17]  I. R. Williams,et al.  Development of prognostic index for primary supratentorial intracerebral tumours. , 1992, Journal of neurology, neurosurgery, and psychiatry.

[18]  D. Nelson,et al.  Long‐Term Survival in Treated Anaplastic Astrocytomas: A Report of Combined RTOG/ECOG Studies , 1991, American journal of clinical oncology.

[19]  S. Brem,et al.  Angiogenesis and blood-brain barrier breakdown modulate CT contrast enhancement: an experimental study in a rabbit brain-tumor model. , 1989, AJR. American journal of roentgenology.

[20]  M. Chamberlain,et al.  Absence of contrast enhancement on CT brain scans of patients with supratentorial malignant gliomas , 1988, Neurology.

[21]  I. Kricheff,et al.  Computed tomography in astrocytomas. A statistical analysis of the parameters of malignancy and the positive contrast-enhanced CT scan. , 1978, Radiology.

[22]  Nickolas Papanikolaou,et al.  Imaging Modalities in Brain Tumors , 2011 .

[23]  A. Drevelegas,et al.  High-Grade Gliomas , 2011 .

[24]  Edward Pan,et al.  Glioblastoma Multiforme and Anaplastic Astrocytoma , 2003 .

[25]  A. Drevelegas,et al.  Imaging of Brain Tumors with Histological Correlations , 2002, Springer Berlin Heidelberg.